allelic exchange is an efficient method of bacterial genome engineering. this protocol describes the use of this technique to make gene knockouts and knock-ins, as well as single-nucleotide insertions, deletions and substitutions, in Pseudomonas aeruginosa. unlike other approaches to allelic exchange, this protocol does not require heterologous recombinases to insert or excise selective markers from the target chromosome. rather, positive and negative selections are enabled solely by suicide vector-encoded functions and host cell proteins. Here, mutant alleles, which are flanked by regions of homology to the recipient chromosome, are synthesized in vitro and then cloned into allelic exchange vectors using standard procedures. these suicide vectors are then introduced into recipient cells by conjugation. Homologous recombination then results in antibiotic-resistant single-crossover mutants in which the plasmid has integrated site-specifically into the chromosome. subsequently, unmarked double-crossover mutants are isolated directly using sucrose-mediated counter-selection. this two-step process yields seamless mutations that are precise to a single base pair of Dna. the entire procedure requires ~2 weeks.
IntroDuctIon
The bacterium P. aeruginosa is one of the most prevalent hospital pathogens in all developed countries [1] [2] [3] . This microorganism is an important laboratory model and a mainstay for studying motility and biofilm formation, as well as cell signaling, virulence and drug resistance in Gram-negative bacteria. Hundreds of P. aeruginosa genomes have been sequenced, and there is an ever-expanding number of genomic resources available for this organism. This includes transposon mutant libraries [4] [5] [6] , an open reading frame (ORF) collection 7 , microarrays 8 , massively parallel sequencing workflows for RNA-seq [9] [10] [11] [12] [13] , ChIP-seq [13] [14] [15] , transposon (Tn)-seq 16 and transcription start-site mapping 10 , as well as a genome database with community-driven annotation 17 .
Yet despite being a highly studied model bacterium, only 18% of the protein coding regions in the P. aeruginosa PAO1 genome have experimentally demonstrated biological roles, and merely an additional ~21% are highly similar to those with a known function in other organisms. The remaining genes have either only generic, homology-derived functional attributes (~22%) or no discernible physiological purpose (39%) 17 . The low-level characterization of these ORFs underscores a continued need for facile techniques to engineer P. aeruginosa strains with precisely defined genotypes. A key technique used for this purpose is allelic exchange, which uses homologous recombination to target an endogenous gene and replace it with a mutant allele.
Allelic exchange has been used to engineer site-directed mutations in a wide range of bacterial species [18] [19] [20] [21] . This method was first applied to P. aeruginosa genetics in the mid-1980s (refs. 22,23) . Over the past 30 years, advances in allelic exchange for P. aeruginosa have been driven by the invention of suicide vectors 22 , the application of conditional lethal genes to counterselection 24 , and the use of heterologous recombinases (such as Flp 20 and Cre 25 ) to remove antibiotic resistance markers after gene replacement. Allelic exchange methods have also benefitted from innovations in cloning technology, including yeast recombineering 26 and Gateway technology [27] [28] [29] [30] [31] . Nevertheless, because the execution of two-step allelic exchange is versatile and varied, application of this method can be daunting even for experienced geneticists. Here we explain the molecular biology of allelic exchange, and we provide a comprehensive and up-to-date protocol for engineering mutations into the P. aeruginosa genome with single-nucleotide precision 28, [31] [32] [33] [34] [35] .
The principle of two-step allelic exchange
Most published methods of allelic exchange in P. aeruginosa depend on plasmids with a ColE1 origin of replication, which replicate in Escherichia coli but not in Pseudomonas species. An assortment of these so-called suicide vectors has been built with suitable antibiotic resistance cassettes and counter-selection markers for manipulating P. aeruginosa ( Table 1) . To facilitate allelic replacement, an allelic exchange vector is engineered with a copy of the gene of interest, which contains the desired mutation, as well as flanking regions of DNA that are homologous to the recipient chromosome. After the construction of this suicide delivery vector, allelic exchange involves two steps (Fig. 1) .
In the first step of allelic exchange, the suicide vector is introduced into P. aeruginosa. This may be accomplished by electroporation 36, 37 . However, most allelic exchange vectors contain the origin of transfer (oriT) from the broad-host-range plasmid RP4 (Table 1) ; therefore, these vectors are most often mobilized by conjugation from E. coli into P. aeruginosa, which is more efficient than electroporation. A site-specific chromosomal integration event, which is mediated by homologous (or Campbell-type 38 ) recombination, must occur in order to obtain resistance to the antibiotic marker encoded on the suicide vector because the ColE1-type plasmids cannot replicate in P. aeruginosa (Fig. 1) . This event is termed a single crossover. Recombination frequency increases with homologous sequence lengths; therefore, the number of antibiotic-resistant merodiploids produced at this first step increases with increasing lengths of vector-encoded homologous sequences.
In the second step of allelic exchange, the plasmid backbone is excised from the chromosome through a rare second homologous recombination event, which is termed a double crossover. This double-crossover mutant is isolated by counter-selection. This is frequently accomplished by selecting for the loss of a gene that confers sensitivity to an agent in the growth medium. Although there are many means of counter-selection 39 , a large number of allelic exchange vectors for Gram-negative bacteria, including those used for manipulating P. aeruginosa, encode the Bacillus subtilis sacB gene ( Table 1) . The sacB gene encodes levansucrase. This enzyme catalyzes the hydrolysis of sucrose and the synthesis of levan polysaccharides, which are high-molecular-weight fructose polymers. Although the molecular basis of toxicity remains unclear, levansucrase activity is localized primarily to the periplasm in Gram-negative bacteria 40 and presumably also in Gram-positive bacteria, such as coryneforms and mycobacteria, for which the sacB system also works as a conditional lethal gene 41, 42 . This activity confers acute sucrose sensitivity 40, 43, 44 , which is dependent on incubation temperature, as well as sodium chloride concentration in the growth medium 45 . Hence, doublecrossover mutants can be selected by growing the first-crossover mutants on sucrose, as only those bacteria that have lost sacB gene expression can grow under this condition. In principle, therefore, sucrose counter-selection results in the loss of either the wildtype or mutant allele from the chromosome. In practice, however, sucrose-resistant merodiploids, which have acquired inactivating mutations in sacB, also appear on occasion (Fig. 1) . This latter phenomenon is termed counter-selection escape 46 . In some bacteria, , because these mutations presumably result from random insertion, deletion or substitution mutations in the sacB gene. Regardless of the underlying causality, all sucrose-resistant merodiploids are easily distinguished from double-crossover mutants because they remain antibiotic-resistant (Fig. 1) .
Advantages of two-step allelic exchange
There are many published procedures for creating mutant alleles in vitro; however, the protocol presented here uses splicingby-overlap extension (SOE)-PCR to construct contiguous mutant alleles that are uninterrupted by antibiotic resistance markers. A similar strategy has been used for engineering unmarked E. coli and Vibrio cholerae strains for nearly 20 years 18, 52, 53 .
This allows for precise, unscarred and unmarked mutations to be selected for at the stage of double crossover (Fig. 1) . This eliminates the need for subsequent Flp-FRT or Cre-lox recombination steps to remove an antibiotic resistance cassette 20, 25, 27 , saving labor, reducing the chance of generating a polar mutation, enabling genome engineering with single-base precision and eliminating risks of off-target recombination 54 . By contrast to this protocol, a primary advantage of creating marked mutations is the ability to apply positive selection for mutants at the stage of second crossover 27 . This can reduce the amount of PCR required to identify mutant strains. However, the subsequent excision of antibiotic resistance cassettes using exogenous recombinases such as Flp 20, 27 requires ~5-7 d of additional work 55 , and leaves a scarred deletion. An empirical comparison of the technique presented in this protocol to an established Flp-dependent method 27 is provided at the end of this introduction.
For further information on gene replacement techniques that require Flp-FRT recombination, we direct the reader to a description elsewhere 20, 27 .
The primary alternative to allelic exchange is PCRmediated gene replacement with the λ Red recombinase system. Red recombineering has been used extensively to engineer E. coli and Salmonella enterica [56] [57] [58] [59] [60] and has been adapted for use with P. aeruginosa 61, 62 . By contrast to the enteric bacteria, however, current protocols for λ Red recombination in P. aeruginosa require very long primers or multi-fragment SOE-PCR to generate mutant alleles 62 . In addition, recipient cells must express the λ Red recombination genes gam, bet and exo, and therefore an initial step is required to transform the recipient strain with a vector that expresses these genes. An advantage of two-step allelic exchange is that once a suicide vector is constructed it can be used directly on many genetic backgrounds of P. aeruginosa. Thus, it is simple to introduce the desired mutation into many strains in parallel or to create multiple mutations in a single strain sequentially. Moreover, there is no need for additional PCR to produce mutant alleles or transformations to create suitable recipient strains.
Finally, this protocol has been troubleshot extensively, being deployed into nine Pseudomonas laboratories in four countries during its development. At the time of this publication, we collectively estimate that our groups have created >1,000 mutants of laboratory strains PAO1 and PA14 with this protocol. In addition, this protocol has been used to engineer strains from a library of environmental 34 and clinical isolates 34, 63 -including those from eye, ear, blood, lung and urinary tract infections-with a success rate of about 50% (ref. 34 ). Altogether, the manipulated isolates belong to the two most abundant phylogenetic groups Figure 1 | Two-step allelic exchange. Host cell proteins drive homologous recombination between the allelic exchange vector and the recipient chromosome. The asterisk denotes any insertion, deletion or base substitution, which may be large (>10 kb for deletions) or as small as a single nucleotide. Dashed lines indicate the outcomes of homologous recombination that are selected at each of the two key steps of allelic exchange. After first crossover, which occurs shortly after conjugation, antibiotic selection (Step 36) is used to select for merodiploids. Subsequently, sucrose counter-selection (Step 37) is used to select for double crossovers. Depending on the physical locus of the second crossover, recombination will either restore the wild-type allele or fix the mutant allele in the bacterial chromosome. A third but rare possible outcome is counter-selection escape. This outcome produces a sucrose-and antibiotic-resistant merodiploid, resulting from an inactivating mutation in sacB. of P. aeruginosa strains, which represent >95% of all genomesequenced strains of this species.
Modifications, applications and limitations
Expert users may find a variety of standard molecular cloning techniques preferable alternatives to those described here. However, deviations from medium compositions and growth conditions provided in this protocol for donor E. coli and recipient P. aeruginosa strains may result in suboptimal results, a reduction in efficiency and even failure to generate mutants.
With the use of vectors encoding appropriate selection and counter-selection functions, this protocol is broadly applicable to engineering the genomes of other bacteria, especially other Pseudomonas and Burkholderia species 64 . In addition to the allelic exchange vectors useful for P. aeruginosa genome engineering (Table 1) , a variety of pEX-based plasmids encoding alternative resistance cassettes (including kanamycin, trimethoprim and tellurite resistance genes) have been put to use in a broad range of Gram-negative bacteria 65, 66 . In addition, there are many alternative strategies for counter-selection, which may be crucial for manipulating bacteria that are insensitive to SacB-mediated sucrose toxicity 46, 67, 68 .
The reader should note that there are several key limitations of allelic exchange:
Allelic exchange depends on host cell recombination proteins, and therefore this protocol cannot be used to manipulate bacteria that are recombination deficient (for example, ∆recA strains). In addition, this protocol may not be equally efficient for all strains, because recombination frequencies can vary considerably between strains of the same species. If there is shared synteny between strains, it may be possible to use a mutant allele generated for one strain to target the orthologous gene in another strain 34, 63 . However, because of natural genetic variation between strains, it is likely that this will introduce additional single-nucleotide polymorphisms (SNPs) in the adjacent regions of homology. Allelic exchange will not be successful at inactivating those genes that are essential for growth under the conditions provided. In P. aeruginosa, the number of essential genes is estimated to be 200-400 (refs. 5,69) . Complementation analysis should be carried out to verify the phenotypes of null mutants. The primary purpose of complementation is to rule out polarity or secondary site mutations as the possible cause of a mutant phenotype. Many genetic tools have been developed for this purpose, including shuttle vectors 29, 70 , site-specific transposons 55, 71 and integrationproficient plasmids 72 . We direct the reader to descriptions of these tools elsewhere 29, 55, [70] [71] [72] .
Experimental design
A basic knowledge of molecular and microbiological techniques is required to execute the genome engineering protocols described
here. These basic techniques are described in standard laboratory manuals for molecular cloning 73, 74 . Novice users should note that examples of enzymes and cloning strategies are provided as part of this protocol; however, expert users will find that a variety of reagents, enzymes and kits may be substituted with appropriate alternatives. Novice users will find additional assistance for generating mutant alleles in the Supplementary Tutorial. Although the Supplementary Tutorial is focused on making a deletion mutation, it illustrates design principles and protocol steps that are shared among all variations of the allelic exchange method.
The process of allelic exchange can be divided into six stages (with a total of 49 short PROCEDURE steps), which are illustrated in the general flowchart ( Fig. 2 Vector selection, primer design and using PCR to synthesize mutant alleles in vitro (Steps 1-12). The initial step for engineering the P. aeruginosa genome is to choose a suitable allelic exchange vector ( Table 1) . The foremost concern is to choose a resistance marker for an antibiotic to which the recipient strain is sensitive. Next, a vector is chosen that allows for one's preferred cloning strategy to insert the mutant allele into the plasmid ( technology ( Table 1) . Because of its quick execution time, cloning efficiency and cost-effectiveness, this protocol relies on the use of Gateway recombineering to create plasmids for allelic exchange (Box 1). Note that all primers must be synthesized with the appropriate attachment or restriction sites, as well as homology extensions, that enable cloning and assembly of the PCR products (Box 2).
Building deletion alleles. Building a deletion allele and confirming a chromosomal 'knockout' requires three primer pairs. The first primer pair ('Up-F' and 'Up-R') targets a genomic region upstream of the desired deletion point, and the second primer pair ('Down-F' and 'Down-R') targets the genomic region downstream of the desired deletion point. Last, a third set of primers ('Seq-F' and 'Seq-R') is designed to sequence through and confirm the
Box 1 | Molecular cloning with in vitro recombineering
A wide variety of standard and commercial cloning techniques are available to molecular biologists. Although it is possible to use any of these approaches here, our group 28, 32 and others 27, 29, 30 have found that Gateway in vitro recombineering has many benefits for cloning mutant alleles and creating allelic exchange vectors. Gateway technology uses the recombination proteins of bacteriophage λ to drive site-specific recombination between attachment (att) sites 101, 102 . Such sites (attB1 and attB2) are synthesized at the 5′ ends of forward and reverse PCR primers (box 2), such that recombination of PCR products with corresponding target sites (attP1 and attP2) in a donor ('pDONR') plasmid is directional. This recombination process, which is mediated by BP Clonase (Invitrogen), produces an entry ('pENTR') vector in which the inserted PCR product is flanked with different attachment sites (attL1 and attL2). Subsequently, the entry vector can be recombined with a destination ('pDEST' or '-GW') vector, which encodes another set of target sites (attR1 and attR2). The recombination of an entry and destination vector is mediated by LR Clonase (Invitrogen), and it produces an expression vector in which the insert is flanked by attB1 and attB2 sites. Thus, the expression vectors can be recombined with donor vectors using BP Clonase. Gateway reactions require 1 h, and they are highly efficient because a typical reaction produces at least 500-1,000 independent clones 103 . In addition, because Gateway vectors exploit ccdB-based counterselection at the transformation step 102 , these reactions yield E. coli clones in which 75-99% of the isolated colonies have the desired insert. Several Gateway-compatible allelic exchange vectors have been created for the purpose of manipulating Gram-negative bacteria, including P. aeruginosa (table 1). A key benefit to this technology is that mutant alleles can be shuttled between donor and destination allelic exchange vectors without the need for addition PCR. This can be invaluable for troubleshooting unforeseen challenges with antibiotic selection, particularly for clinical isolates. Gateway recombinational technology, therefore, can substantially accelerate the process of gene replacement. The use of Gateway technology is inexpensive (currently, a half-volume Clonase reaction, which is used in this protocol, costs ~$5 USD), and it creates additional economy, relative to restriction-and-ligation, by substantially reducing hands-on time and increasing cloning efficiency.
Box 2 | Guidelines for primer design
• Primer sequences are dictated by the target amplicon; however, there may be some flexibility in the target. Whenever possible, choose a region of target DNA in which the GC content is <70%, and primers should have no more than a 3:1 GC:AT ratio or vice versa. The GC content of the P. aeruginosa genome is ~66.6% (ref. 104 ), but ideally primers will have a GC content of between ~55 and 68%.
• Calculate primer melting temperature using an algorithm that corrects for salt concentration. Oligocalc (http://www.basic.northwestern. edu/biotools/oligocalc.html) is a free web tool that can be used to calculate salt-adjusted melting temperatures 105 .
• Primers should have a salt-adjusted melting point of 62 ± 2 °C for the region of homology to the target amplicon.
• Regions of reverse complementarity to another DNA fragment, which are used to facilitate assembly of PCR products during SOE-PCR, should have a salt-adjusted melting point of 70 ± 1 °C.
• Sequencing primers are best as 17-to 20-mers with melting points of 50-60 °C (i.e., the 'Seq-F' and 'Seq-R' primers in Fig. 3 ).
• Primers must not have long regions (i.e., >6 bp) of self-complementarity that could be predicted to form secondary structures.
In addition, ensure that primers do not self-anneal, or have complementarity to their partner; this helps avoid the formation of primer dimers.
• Primers can be flanked by any desired sequence, including an attachment sequence (such as an attB sequence for Gateway cloning) or a restriction site. Some frequently used restriction and attachment sites are as follows (underlined regions correspond to the DNA sequence recognized by the enzyme):
5′-ATC CGG AAG CTT-3′ HindIII 5′-ATC CGG CTG CAG-3′ PstI 5′-ATC CGG GGA TCC-3′ BamHI 5′-ATC CGG GAA TTC-3′ EcoRI 5′-GGG GAC AAG TTT GTA CAA AAA AGC AGG CTC A-3′ attB1 5′-GGG GAC CAC TTT GTA CAA GAA AGC TGG GTA-3′ attB2
 crItIcal Do not include these extra sequences in the calculation of melting temperature.  crItIcal An extra 4 and 6 bp have been added at the end of a primer with an attachment or a restriction site, respectively. The additional DNA is required to facilitate enzyme binding to the substrate.
deletion of the site for the putative mutation on the chromosome (Fig. 3a) . These primers are typically designed outside the targeted upstream and downstream regions of homology (Fig. 3a) . However, it is possible to nest these primers within the regions of homology, especially if cloning the targeted PCR amplicon has proven to be difficult. In lieu of this third set of primers, it is possible to use the 'Up-F' and 'Down-R' primers that were used to clone the upstream and downstream fragments, respectively, to identify deletion mutants at the last stage of this protocol. However, because these primers are tailed with attachment or restriction sites, the 'Up-F' and 'Down-R' primers will not always be suitable for sequencing the region of the deletion following counter-selection. An effective deletion strategy typically leaves a miniature ORF that encodes a short polypeptide, and the goal is to delete 95-99% of the target gene. To create a deletion mutation that is in-frame, the 'Up-R' and 'Down-R' primers are designed so that their 5′-ends are a multiple of 3 nt from the start and stop codons, respectively (Fig. 3a) . These stipulations for creating in-frame deletions, however, still allow primers to be designed with some flexibility. Similar to most other prokaryotes, the average ORF length in the P. aeruginosa PAO1 genome is ~1.0 kb (ref. 76 ). To create a deletion of this size, a sequence length of ~400-500 bp for each of the upstream and downstream homologous regions is sufficient to drive recombination with the P. aeruginosa chromosome at readily selectable frequencies. The size of these regions of homology should be increased for larger deletions, and including an additional ~50-100 bp for each additional 1 kb of DNA being deleted from the chromosome is recommended. For example, this protocol was used to delete an 11.5-kb region from the P. aeruginosa PAO1 R2 pyocin gene cluster (PA0615-PA0628) using a construct that contained a total of ~1.8 kb homology to the chromosome 28, 77 . To create a deletion allele, the two PCR products encoding regions flanking the deletion point are assembled by SOE-PCR 78 . To facilitate assembly of the two fragments, one of the primers ('Up-R' or 'Down-F') is designed with an extension that has reverse complementarity to the other fragment ( Fig. 3a and 
Box 2).
The reader should note that target genes may contain promoter elements, ribosomal binding sites or start codons for adjacent ORFs. It is also possible that targeted sequences may be expressed as noncoding RNA from the opposing strand or may contain a site for epigenetic modification. Mutagenesis of these target genes can be carried out in ways that are predicted to reduce or eliminate polar effects that may affect the expression of downstream genes or operons. For instance, it is possible to use genome sequence data to exclude predicted ribosomal binding sites and start codons from chromosomal regions targeted for deletion. In addition, it is possible to introduce a nonsense mutation into a target gene that contains overlapping promoter elements. Such a strategy could be used to create a truncated ORF that encodes a short polypeptide but leaves transcriptional elements of the adjacent gene intact (see 'Building alleles and gene fragments with SNPs' in the INTRODUCTION, below). In P. aeruginosa, for example, this approach has been used to truncate the fleN ORF, which contains a promoter for the adjacent fliA gene 79 .
Building insertion alleles. This protocol may be used to introduce an exogenous genetic element into the chromosome. Building an insertion allele and confirming a chromosomal 'knock-in' requires at least four primer pairs. The first primer pair ('Up-F' and 'Up-R') targets a genomic region upstream of the desired insertion point, and the second primer pair ('Down-F' and 'Down-R') targets the genomic region downstream of the desired insertion point. The third primer pair ('Ins-F' and 'Ins-R') targets the exogenous genetic element to be inserted into the genome. Finally, a fourth set of primers ('Seq-F' and 'Seq-R') is designed to read through the putative insertion site on the chromosome (Fig. 3b) . To facilitate assembly of the three fragments, two of the primers ('Up-R' or 'Ins-F' and 'Ins-R' or 'Down-F') are designed with extensions that have reverse complementarity to one of the other fragments (Fig. 3b) . The individual fragments are amplified in a first round of PCR, and then all three are combined and fused in a second round of SOE-PCR. In principle, it may be possible to assemble more than three PCR fragments together at this step.
The ability to create precise insertion mutations with allelic exchange has many potential applications. For example, it is possible to create an unscarred knock-in of a transcriptional regulator and inducible promoter element (for example, E. coli araC-P BAD 28, 35, 80 ) upstream of a gene or operon in order to gain artificial control over its expression. Other useful applications include the insertion of epitope tags into proteins, or the fusion of an ORF with a fluorescent protein [81] [82] [83] .
Building alleles and gene fragments with SNPs. Constructing a de novo mutant allele with a SNP, short deletion or insertion mutation may be carried out using well-established protocols for site-directed mutagenesis by SOE-PCR 84 . Briefly, this approach uses two pairs of primers, each of which targets a 400-500-bp segment of the genome; however, the internal primers generate overlapping, complementary 3′ ends on the intermediate segments and introduce nucleotide substitutions (Fig. 3c) . The SOE-PCR product is thus an ~800-1,000-bp DNA fragment in which the point mutation is approximately centered within a contiguous region of homology to the target chromosome. Note that the central position of the point mutation is critical: if the point mutation is near either end of the homologous region, then this will markedly reduce the probability that a secondcrossover event will incorporate the mutation into the chromosome. Alternatively to SOE-PCR, a mutant allele, or a fragment of that allele, can be cloned directly by PCR from a strain bearing the desired mutation. Such an approach may be useful for understanding the fitness benefits of SNPs that have evolved in laboratory strains or clinical isolates 77, 85 . Finally, a set of primers ('Seq-F' and 'Seq-R') is designed to read through the putative mutation site on the chromosome (Fig. 3c) . Importantly, these primers are used for Sanger sequencing to identify the P. aeruginosa recipients that have acquired the desired mutation at the final stage of this protocol.
Cloning the mutant allele into an allelic exchange vector (Steps 13-19).
Any cloning method can be used to create an allelic exchange vector containing the synthesized mutant allele; however, this can be accomplished rapidly with a single, hour-long enzymatic step that uses Gateway technology (Box 1). In this protocol, attB1-and attB2-flanked PCR products are transferred into a suitable donor allelic exchange vector using BP Clonase II (Invitrogen). Alternatively, the attB1-and attB2-flanked SOE-PCR product can be cloned first into another entry vector, such as pDONR221 (Km r , Invitrogen) or pDONR223 (Sp r ) 86 . The reaction is then transformed into E. coli DH5α using standard chemical methods or electroporation (Box 3). If the reader has elected to clone into pDONR221 or pDONR223 as a first step, the resulting entry clone, which is identified by screening for insertions and then Sanger sequenced, is recombined with a suitable destination allelic exchange vector ( Table 1) in a second recombination step (Box 4). Subsequently, the process of screening for plasmid insertions and Sanger sequencing is repeated. However, this two-step Gateway cloning approach adds at least 4 d to the protocol (Box 4). Thus, the most efficient way of Gateway cloning is to insert the mutant allele directly into a donor allelic exchange vector ( Table 1) . Subsequently-and only if required-a destination allelic exchange vector, which can be created by LR Clonase-mediated recombination between the destination and entry allelic exchange vectors, can be produced if there is a need for an alternate antibiotic marker for merodiploid selection (Box 4).
PCR identification and sequencing of insertions in allelic exchange vectors (Steps 20-35).
Colony PCR is used to quickly and directly screen E. coli colonies to identify those clones bearing allelic exchange vectors in which the mutant allele has been inserted. If any approach other than Gateway cloning has been used, then this process may be guided by standard practices for blue-white selection 19, 20 . By contrast, blue-white selection is not applicable to Gateway cloning, and instead this approach uses ccdB counter-selection to select for clones with inserts. CcdB is a gyrase-subunit A-modifying enzyme that poisons DNA gyrase in E. coli cells and blocks bacterial growth 87 . Gateway donor and destination vectors encode ccdB on the interior of their att sites, and therefore these plasmids cannot be propagated in E. coli DH5α (these plasmids are maintained in strains, such as DB3.1 or ccdB
Box 3 | Preparation of electrocompetent E. coli • tIMInG ~1 d
Survival 2 cells from Invitrogen, that have mutations in gyrA that confer resistance to CcdB). However, a successful recombination event causes the ccdB gene to be lost from Gateway vectors, providing positive selection for recombinants in the DH5α strain. Thus, >75% of the Gateway clones typically have the insert at this stage without the need for further selection. All pEX18-and pEX19-based vectors contain M13F and M13R primer-binding sites, and thus all clones may be screened by PCR for inserts, and even sequenced, using the M13 universal primers (Supplementary Table 1 ). PCR occasionally introduces unwanted mutations into the synthesized alleles, and therefore two independent clones that test positive for the insert by PCR are streaked for isolation. Next, plasmid DNA is purified from each clone and confirmed via Sanger sequencing. Gateway vectors are difficult templates for Sanger sequencing, and therefore it is crucial to inform your service provider about the nature of the template so that the sequencing protocol can be modified accordingly.
Introduction of the mutant allele into a P. aeruginosa recipient and merodiploid selection (Step 36). Although allelic exchange vectors can be transformed into P. aeruginosa cells by electroporation 37 , we have found that the average number of merodiploids recovered from biparental mating is at least 10-100-fold greater: electroporation produces on the order of 10 1 -10 2 merodiploids 37 , whereas biparental mating produces on the order of 10 2 -10 4 merodiploids (see ANTICIPATED RESULTS). Therefore, this protocol uses conjugation to transfer suicide plasmids from an E. coli donor to the P. aeruginosa recipient, and we direct the reader to a description of electroporation elsewhere 37 . A useful tool for biparental mating is a reusable syringe filter apparatus (see Equipment Setup), which presumably brings donor and recipient cells into close physical proximity to one another (Fig. 4) . In our hands, this 'mating' filter is a quick, reliable and alternative means of recovering merodiploids that is comparable in efficiency to carefully executed 'puddle' mating (see ANTICIPATED RESULTS). We provide options for biparental 'filter' and 'puddle' mating techniques, and either may be used at the preference of the reader.
Here we advocate the use of nutritional counter-selection as opposed to antibiotics to prevent the growth of the E. coli donor strain during the isolation of P. aeruginosa merodiploids after mating. Vogel-Bonner minimal medium (VBMM) agar, which contains 10 mM citrate as a carbon source, can be used to select against E. coli 88 . Because E. coli does not express a citrate transporter during aerobic culture 89 , it cannot use citrate as a carbon source, and therefore E. coli will not grow on VBMM in an aerated incubator. The recovery of P. aeruginosa merodiploids on VBMM
Box 4 | Transferring mutant alleles between gateway vectors • tIMInG 4 d
A mutant allele can be transferred from an entry vector (with attL sites) into a destination allelic exchange vector (with attR sites) in a single reaction. Such a transfer is crucial, for example, when using pDONR221 or pDONR223 as a first step in Gateway cloning. In addition, transferability between vectors encoding alternate antibiotic resistance cassettes is also highly useful when optimizing allelic exchange to engineer drug-resistant P. aeruginosa isolates. The following protocol has been adapted from the Gateway technology manual (Life Technologies), and it uses half of the recommended LR Clonase enzyme mix. This offers considerable savings to the user. agar may require up to 48 h of incubation at 37 °C. By contrast, this recovery process may take <24 h at 37 °C on nutrient-rich lysogeny broth (LB) agar containing Irgasan (also called triclosan) and/or chloramphenicol. However, we have observed that the use of VBMM results in the recovery of ≥10-fold more merodiploids than LB agar with either Irgasan-or chloramphenicol-based counter-selection (Supplementary Fig. 1 ). This discrepancy in recovery rate is not understood. However, because this phenomenon occasionally leads to protocol failure ( Supplementary  Fig. 1) , we recommend the use of VBMM agar for the isolation of merodiploids. Alternatively, we also recommend the use of auxotrophic E. coli donor strains, such as ST18 (ref. 90) or RHO3 (ref. 66) , which require the addition of 5-aminolevulinic acid (ALA) or diaminopimelic acid (DAPA) to the LB agar medium, respectively, in order to grow. In the case of this latter substitution, biparental mating with ST18 or RHO3 is carried out on LB agar containing ALA or DAPA, respectively. Subsequently, merodiploids can be selected directly on LB agar containing only antibiotic selection for the P. aeruginosa recipient.
Counterselection, PCR identification and sequencing of mutations in P. aeruginosa cells (Steps 37-49) . The final stage of allelic exchange is to select against merodiploids and to identify the desired mutants. This is accomplished by streaking isolated merodiploids on no-salt LB agar that contains 15% (wt/vol) sucrose. In the case of large deletions or insertions, single colonies isolated on sucrose agar are screened for the desired mutation by PCR using 'Seq-F' and 'Seq-R' primers (Fig. 3) . These individual colonies are spotted onto selective media. PCR products, which correspond to the size of the mutant allele and that were generated from sucrose resistant and antibiotic sensitive colonies, are subsequently sent for Sanger sequencing to confirm the mutation. In the case of small deletions and insertion mutations, as well as SNPs, PCR products from 8-16 of the sucrose-resistant and antibiotic-sensitive colonies are sent for Sanger sequencing. Subsequently, the desired mutant is identified by sequence analysis.
Procedural controls
In general, positive and negative controls for routine PCR, cloning reactions or transformations-such as those that contain control templates, no DNA or no enzyme-are noninformative for most steps, and moreover they may be redundant because all constructs and strains are sequence verified as part of this protocol. In addition, positive controls involving the use of control plasmids to verify Gateway Clonase reactions (as recommended by the manufacturer) may add considerable expense to the protocol while yielding no additional value. Thus, readers must exercise judgment with procedural controls, and we recommend applying these specifically when repeating failed steps (see TROUBLESHOOTING). However, users may find it highly beneficial to test selective media either when fresh batches are made or by including appropriate antibiotic-resistant and antibiotic-sensitive strains at key selection steps (for example, Step 39; Supplementary Tutorial). We also recommend including a control with no template (i.e., boiled colony) when using PCR to identify newly generated strains with an unmarked mutation (Steps 38-45).
Comparison with Flp-dependent protocols for marked mutant generation
We compared the present protocol with an established method for generating marked mutations that requires subsequent excision of a gentamicin (Gm) resistance marker (aacC1) by Flp-FRT recombination 27 . To begin, we used the present protocol to engineer A total of 25 precise, unscarred, unmarked mutations were constructed using the present protocol. By contrast, three marked mutations were generated using the established method of Choi and Schweizer 27 . This latter method requires an additional Flp-FRT recombination step to excise the aminoglycoside acetyltransferase (aacC1) antibiotic resistance cassette, leaving a scarred mutation. In both panels, blue represents a gene deletion that was loss-of-function, vermillion represents a gene deletion that had no effect on the diameter of the twitching motility zone and white represents a gene that was not subject to mutation. This genetic analysis produced motility phenotypes that were consistent with previous reports 95 , which includes no change in motility zone diameter for ∆fimT, ∆pilY2, ∆pilH and ∆chpB strains 95, 96 . Because pilY2, pilH and chpB occur within operons, this analysis illustrates the precision of the allelic exchange technique. Moreover, the two methods of mutation construction gave similar results.
precise, unmarked deletions at 25 gene loci encoding components of the P. aeruginosa type IV pilus (see ANTICIPATED RESULTS). Next, we used the allelic exchange vector pDONRPEX18Ap ( Table 1 , encodes β-lactamase) to engineer marked ∆pilC::aacC1, ∆pilR::aacC1 and ∆pilN::aacC1 mutant strains (Fig. 5) . For the sake of comparison, deletion alleles marked with aacC1 were created with homology regions identical to those used to generate ∆pilC, ∆pilR and ∆pilN alleles. Not surprisingly, merodiploids were recovered at a frequency equivalent to that of unmarked mutants (Fig. 6a) . Similar to this protocol (Fig. 6b) , counter-selection on no-salt LB (NSLB) + 15% (wt/vol) sucrose + 60 µg/ml
Gm yielded double-crossover mutants at a frequency of <10 −5 . However, 100% of the carbenicillin (Cb)-sensitive, Gm-resistant colonies contained the desired aacC1-marked mutation (compared with 46% for the present protocol; see ANTICIPATED RESULTS). Although this is a beneficial aspect of generating marked mutations, subsequent excision of the aacC1 gene by established methods 27 required an additional 6 d of work and resulted in a scarred mutation. By contrast, the 'Flp-free' technique presented in this protocol is at an advantage because this last step is not required. This saved nearly 1 week of work and resulted in mutations that were seamless. Figure 6 | Outcomes of merodiploid selection and sucrose counter-selection using the two-step allelic exchange protocol. (a) Numbers of merodiploids recovered after biparental mating (Step 36). Each datum point represents an independent mating with pEX18Gm, pDONRPEX18Gm, pDONRPEX18Ap or pEX18GmGW vectors, each containing one of 37 different mutant alleles. Data have been normalized to the length of the regions of homology to the recipient chromosome. Solid lines and error bars represent the mean number and s.d., respectively, of P. aeruginosa merodiploids recovered after conjugation. *P ≤ 0.05 with Student's t-test. Elevated incubation temperatures after conjugation (Step 36A(x)) increase the number of merodiploids recovered in the subsequent PROCEDURE step (Step 36A(xi)). However, the lower temperature (30 °C) is used to minimize clonal expansion. There is no difference in the number of merodiploids recovered after use of the filter or puddle mating techniques (Step 36A versus 36B). Finally, similar numbers of merodiploids are generated by this protocol and established methods 27 for generating marked mutations. (b) Frequency of sucrose-mediated counter-selection of double-crossover mutants (~10 −5 on NSLB + 15% (wt/vol) sucrose) and counter-selection escape (<10 −7 , on NSLB +15% (wt/vol) sucrose + 60 µg/ml gentamicin (Gm), not detectable in this assay). Selection frequency for double-crossover mutants and counter-selection escape is shown for three independent experiments. REAGENT SETUP  crItIcal Unless noted otherwise, all buffers and sterile broth media may be prepared ahead of time and stored for at least 6 months at room temperature (25 °C). Antibiotic stock agents should be added to broth medium immediately before use. Petri plates with solidified agar medium prepared with or without antibiotics may be wrapped in plastic sleeves and stored upside down at 4 °C for at least 4 months. Agar medium containing Tc must be wrapped with aluminum foil to protect it from light during storage. Antibiotics Prepare stock agents at 100× (for Tc) or 1,000× concentration (all other antibiotics) ( Table 2 ) in the appropriate solvent. Sterilize water-soluble antibiotics by filtration. Divide all stock solutions into 1.0-ml aliquots and store them at −20 °C until needed.  crItIcal Antibiotic concentrations must be normalized for activity, which varies from lot to lot. Activity, which is determined by bioassay by the manufacturer, is usually written on the label or on the certificate of analysis for the lot. Note that chloramphenicol (Cm) and Tc are light-sensitive, and they must be stored in the dark. Wrap stock solutions in tinfoil and store them at −20 °C. LB medium Mix 10 g of Bacto tryptone, 5 g of yeast extract and 5 g of NaCl, and bring the volume up to 1 liter with ultrapure water. Adjust the pH to 7.2. Sterilize the medium by autoclaving at 121 °C. Allow the medium to cool and add antibiotics as required. LB agar Mix 10 g of Bacto tryptone, 5 g of yeast extract, 5 g of NaCl and 15 g of Bacto agar, and bring the volume to 1 liter with ultrapure water. Adjust the Figure 4 . Wrap the assembled filters in aluminum foil. Sterilize by autoclaving at 121 °C with an additional drying cycle.  crItIcal Membrane filters must have a pore size of 0.45 µm, because filters with smaller pores sizes will clog and filters with larger pore sizes will not retain bacterial cells. In addition, many filters are sold in packages with paper inserts that separate the individual PVDF membranes. It is crucial to ensure that these paper inserts are removed and not inadvertently inserted into the filter holder. proceDure Vector selection and primer design • tIMInG 1 h on 1 d 1| Precisely design your desired mutant allele, allelic exchange vector and required primers in silico (see Experimental design). This is greatly facilitated by the use of DNA sequence analysis software such as Geneious (Biomatters), Vector NTI (Life Technologies) or ApE (http://biologylabs.utah.edu/jorgensen/wayned/ape/). Primer sequences may be generated by using PCR primer design algorithms included with the sequence analysis software, or, alternatively, by using a text editor and online tools and following a simple set of guidelines (box 2). The genome sequences of the laboratory P. aeruginosa strains are available from the Pseudomonas genome database (http://www.pseudomonas.com).  crItIcal step Be sure to include the 5′ primer extensions that encode restriction sites, attachment (att) sites or regions of complementarity that are used for the chosen method of cloning (box 2).
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2|
Order or synthesize the required primers (ssDNA oligomers) as salt-free, but otherwise unpurified.
3|
Dissolve lyophilized primer DNA in TE buffer, pH 8.0, to produce a primer stock solution with an ssDNA concentration of 100 µM (i.e., add 10 µl of TE buffer per nanomole of DNA).
pcr to build mutant alleles in vitro • tIMInG 6 h on 1 d 4| Set up a 5-or 10-reaction high-fidelity PCR master mix in order to amplify the target DNA fragments, as follows:  crItIcal step High-fidelity polymerases have a proofreading (3′→5′) exonuclease activity that can degrade PCR primers. If a delay is anticipated between the addition of the polymerase and the start of the thermal cycler, then the PCRs should be kept on ice (4 °C).
5| Add 20.0 µl of the master mix into PCR tubes or wells of a PCR plate.  crItIcal step Arrange aliquots of each master mix in the PCR plate so that they are oriented parallel to the temperature gradient of the thermal cycler.
6|
Move the PCRs to the thermal cycler and run the PCR program as follows (based on optimal conditions for Phusion DNA polymerase):  crItIcal step There is no need to hold the temperature below 10 °C for the routine cloning of DNA. Holding at 10 °C minimizes wear on Peltier heating systems, which are in most thermal cyclers, and can substantially extend the life span of the instrument.  pause poInt PCRs may be stored at 4 °C for at least 1 week and at −20 °C for at least 1 month.
7| Pour a 1.0% (wt/vol) TAE + G gel and add the nucleic acid gel stain directly to the gel. Load 10-µl aliquots of the PCR products with 6× gel loading dye into the wells of the gel along with an appropriately sized DNA ladder. Run the gel and then image it using an UV transilluminator and digital camera.
? troublesHootInG 8| Using a new razor blade, cut out DNA bands of the appropriate size and place each slice in a separate 2.0-ml microcentrifuge tube.  pause poInt Gel slices containing DNA may be stored at 4 °C for up to 1 week.
9|
Purify the DNA using a gel purification kit. Elute the DNA into Tris-HCl buffer using buffer volumes recommended by the manufacturer of the gel purification kit.  crItIcal step Ensure that the silica-membrane column (e.g., QIAquick gel extraction kit) or silica particles (e.g., QIAEX II gel extraction kit) are completely dry before eluting the DNA into Tris-HCl buffer.
10|
Determine the concentration and purity of the eluted DNA by measuring the absorbance at 260 nm and 280 nm (A 260 and A 280 ) on a UV spectrophotometer.  pause poInt Purified DNA may be stored for the short (<1 week) at 4 °C or long (>1 week) term at −20 °C.
11|
Set up a five-or ten-reaction high-fidelity SOE-PCR master mix in order to assemble and amplify the desired mutant allele as follows:  crItIcal step If a delay is anticipated between the addition of the polymerase and the start of the thermal cycler, then the PCRs should be kept on ice (4 °C).
12|
Repeat Steps 5-10 to amplify, image, purify and quantify the SOE-PCR product, increasing the extension time of the PCR (as described in Step 6) to allow for the amplification of a longer amplicon. ? troublesHootInG cloning the mutant allele into an allelic exchange vector • tIMInG 3 h on 1 d 13| To insert the assembled mutant allele from Step 12 into the chosen allelic exchange vector using Gateway technology, set up a half-volume reaction by adding the following components to a 0.2-ml PCR tube or a well of a PCR microplate: 0.50 µl of Gateway donor vector (100 ng/µl) and a volume of purified SOE-PCR product corresponding to 10-25 ng of DNA, and bring the volume to 4.0 µl with TE buffer, pH 8.0.  crItIcal step The PCR product can alternatively be cloned into the allelic exchange vector using another standard technique (as described in Experimental design).
14|
Thaw the BP Clonase II enzyme mix on ice for 2 min. Vortex the mix briefly twice (for 2 s each time). Add 1.0 µl of BP Clonase II enzyme mix to the reaction. Carefully and thoroughly mix the reaction using a micropipette.  crItIcal step If the reaction mixture has dispersed in the PCR tube, perform a quick-spin in a minicentrifuge to collect the contents at the bottom of the tube.
15| Incubate the Gateway cloning reaction for 1-3 h at room temperature. For increased efficiency, this reaction may be left overnight on the bench top.
16|
Add 0.5 µl of the proteinase K (provided with the BP Clonase II enzyme mix) to the reaction mixture. Incubate it for 10 min at 37 °C.
17|
To transform chemically competent E. coli DH5α (e.g., Zymo5α Mix & Go competent cells; high transformation efficiency, i.e., >10 8 transformants per µg of pUC19 DNA), add 2.5 µl of the recombination, ligation or assembly mix to a 50-µl aliquot of thawed competent cells, and then incubate the cells on ice for 5-45 min.  crItIcal step Note that there is no need to desalt the Gateway, ligation or assembly reaction before proceeding.  crItIcal step Electrocompetent E. coli DH5 cells can be used instead, as described in box 3.
18| Add 0.5 ml of SOC medium and transfer the transformed cells to a sterile culture tube. Incubate the cells for 1 h at 37 °C and 250 r.p.m.  crItIcal step Note that it is not necessary to outgrow E. coli cells that have been transformed with a vector encoding a β-lactamase, which confers resistance to ampicillin (Ap) or Cb.
19|
Plate 50-and 450-µl aliquots on LB agar with the appropriate antibiotic selection and incubate for 20-24 h at 37 °C.
? troublesHootInG screening for insertions in allelic exchange vectors and sanger sequencing • tIMInG 7 h over 3 d 20| Use a P20 micropipette to collect a tiny amount of a bacterial colony from the selective agar plate from Step 19, and then suspend it in 50 µl of ultrapure water. Typically, four colonies are screened for each plasmid being constructed.  crItIcal step The bacterial suspension should be only faintly turbid. Using too much starting material can inhibit the downstream PCR.
21| Use a multichannel pipette to transfer 3.0 µl of each colony in suspension onto a selective agar plate. Let these 'spot' plates dry and then incubate them at 37 °C overnight. Note that each 3-µl droplet put onto the plate will grow into a colony that can be streaked out for isolation (as described in Step 28) once the clone with the desired insert has been identified by PCR (as detailed in Steps 22-27).
22|
Boil the remaining cells in suspension using a thermal cycler set at 100 °C for 5 min. After boiling, add 103 µl of ultrapure water to each well in order to dilute the plasmid DNA.  crItIcal step If the template concentration is too high, DNA polymerase can be inhibited.
23|
Create a colony PCR master mix using GoTaq flexi DNA polymerase as follows:  crItIcal step To time the PCRs with the growth of bacterial colonies prepared in Step 21, it is possible to run the thermal cycler overnight.
27| Pour a 1.0% (wt/vol) TAE + G gel. Load 10-µl aliquots of the PCR products with 6× gel loading dye into the wells of the gel along with an appropriately sized DNA ladder. Run the gel and then image it using standard techniques with a UV transilluminator and digital camera.
? troublesHootInG
28|
Use the results of colony PCR to identify clones with the desired insert. This identification is based on the size of the band in the gel. Clones containing the desired insert will produce a PCR product that is equal to the size of the SOE-PCR product plus the distance between M13F and M13R priming sites (or the target sites of alternative sequencing primers used in Step 26) and the cloned insert (supplementary tutorial). On the basis of this identification, pick a colony from the corresponding spot plate prepared in Step 21. Streak this colony out on LB agar containing appropriate antibiotic selection. Pick and streak out a second colony from the same plate using the same criteria. Incubate these plates at 37 °C overnight.
29|
For each streak plate grown in the previous step, transfer 1 ml of sterile PBS into a 2-ml microcentrifuge tube. Use a sterile polyester-tipped swab to collect a 3-4 cm 2 lawn of bacteria from the surface of each agar streak plate. Suspend the collected bacteria in sterile PBS.  crItIcal step Retain the streak plates at 4 °C for up to 1 week.
30|
Collect the cells by centrifugation at ≥10,000g for 1 min at room temperature. Discard the supernatant.
31|
Use a plasmid DNA isolation kit (e.g., QIAprep spin miniprep kit) to isolate and purify the plasmids, according to the manufacturer's instructions. Elute the plasmids in 50 µl of Tris-HCl, pH 8.5.
32|
Determine the concentration and purity of the eluted DNA by measuring the A 260 and A 280 on a UV spectrophotometer. The plasmid preps should yield ~5-20 µg of DNA each with an A 260 /A 280 ratio of 1.8-2.0.
33|
Send the purified plasmids for Sanger sequencing using a preferred outsource. M13F(-21) and M13R universal primers, which are provided free of charge by many Sanger sequencing providers, may be used for sequencing the mutant allele in any pEX18-based plasmid (table 1), or in pDONR221-or pDONR223-based plasmids.  crItIcal step Gateway vectors are often considered difficult templates for the purposes of Sanger sequencing; however, adjustments can be made to the sequencing protocol to accommodate these vectors if the sequencing provider is informed at the time of sample submission.
34|
Analyze the sequence of the plasmid using the BLASTN 92 (http://www.pseudomonas.com) or CLUSTALW 93 (http://www. genome.jp/tools/clustalw/) tools. Choose one plasmid that has a 100% match to the predicted sequence for use as the allelic exchange vector.
35|
Prepare a glycerol stock of the E. coli DH5α strain harboring the plasmid of interest. To do this, add 1 ml of LB and 0.5 ml of sterile glycerol (50% (wt/vol)) to a screw-capped 2-ml tube. Next, use a polyester-tipped swab to collect a 3-4-cm 2 lawn of bacteria from the surface of the agar streak plate (retained at Step 29) corresponding to the plasmid that has a 100% match to the desired sequence. Suspend the bacteria in the LB-glycerol solution. Freeze the glycerol stock at −80 °C.  pause poInt E. coli DH5α cell lines may be stored indefinitely at −80 °C.
Introduction of the mutant allele into a P. aeruginosa recipient and merodiploid selection • tIMInG 9 h over 4 d 36| Transform a donor E. coli strain, and then use conjugation to introduce the allelic exchange vector into P. aeruginosa using either a mating filter apparatus (option A) or standard 'puddle mating' (option B): (a) Mating filter apparatus (i) Transform the allelic exchange vector from Step 34 into a suitable donor E. coli strain, such as S17.1 (λ pir + ) or SM10 (λ pir + ), using a standard chemical transformation or electroporation protocol (box 3). On the same day, streak out the recipient P. aeruginosa strain on LB agar. Allow it to grow overnight at 37 °C. (ii) Pick a single colony of the transformed donor E. coli strain and streak it out on LB agar with appropriate antibiotic selection. Incubate the agar plate overnight at 37 °C. On the same day, pick a single colony of the recipient P. aeruginosa strain and inoculate it in 3 ml of LB. Allow it to grow overnight at 37 °C and 250 r.p.m. (iii) Prepare a glycerol stock of the E. coli donor strain (Step 35). Freeze the glycerol stock at −80 °C.
 pause poInt E. coli donor cell lines may be stored indefinitely at −80 °C. It is possible to resume this protocol at
Step 36A(i) with a fresh streak plate of the E. coli donor taken from cryogenic storage. (iv) Add 3 ml of fresh LB to the overnight culture of the recipient P. aeruginosa strain from Step 36A(ii). Incubate the culture at 42 °C for a minimum of 3 h or until the donor strain has reached an optical density at 600 nm (OD 600 ) value of 0.5-0.6 (as detailed in next step).  crItIcal step Incubation at 42 °C reduces some of the antibacterial effectors produced by P. aeruginosa and makes it more amenable to mating. (v) At the same time that the recipient strain is diluted, pick a single colony of the transformed donor E. coli strain from
Step 36A(ii) and inoculate it in 3 ml of LB. Allow the colony to grow at 37 °C and 250 r.p.m. to an OD 600 of 0.5-0.6 (~3-4 h). (vi) Prewarm an LB agar plate to 30 °C. (vii) Assemble a mating filter apparatus (Fig. 4) . Pull the plunger out of a sterile 10-ml syringe. Join the 10-ml syringe to a sterile filter holder.  crItIcal step Ensure that the O-ring is in place and that the Luer lock joints and the filter chamber are sealed tightly. (viii) Place the assembled apparatus over the open top of a 50-ml Falcon tube. Add 3 ml of the donor E. coli strain from
Step 36A(v) and 1 ml of the recipient P. aeruginosa strain from Step 36A(iv) to the syringe. Insert the plunger into the syringe and press the bacterial culture through the mating filter apparatus. The bacteria will collect in a thin layer on the top of the filter. (ix) Remove the syringe and discard it in a biohazard waste container. Using aseptic technique, unscrew the top of the filter holder. Use flamed tweezers to transfer the filter to the surface of the prewarmed LB agar plate.  crItIcal step Ensure that the bacteria on the surface of the filter are facing upward. Do not sandwich the bacteria between the agar surface and the filter. (x) Incubate the LB agar plate with the mating filter overnight at 30 °C. (xi) Use a sterile plastic inoculation loop to scrape the bacterial lawn off of the filter and suspend in 1.0 ml of sterile PBS. Mix the suspension by pipetting it up and down with a P1000 micropipette. Plate 10-, 100-and 500-µl aliquots on VBMM agar plates with the appropriate antibiotic selection, and incubate them for 48 h at 37 °C.
? troublesHootInG (b) puddle mating (i) Transform a suitable E. coli donor strain and grow the E. coli donor and the P. aeruginosa recipient as described in
Step 36A(i-vi). (ii) Into each of two 2-ml microcentrifuge tubes, add 1.5 ml of the E. coli donor strain and 0.5 ml of the P. aeruginosa recipient strain. Collect the cells by centrifugation at 10,000g for 5 min at room temperature. Discard the supernatant.
Resuspend each cell pellet in 50 µl of LB and combine them. Transfer this cell mixture onto the middle of the prewarmed LB agar plate. Allow the 'puddle' to dry on the agar surface. Incubate the LB agar plate overnight at 30 °C. (iii) By using a sterile plastic inoculation loop to scrape the bacterial 'puddle' off of the surface of LB agar plate, repeat
Step 36A(xi).
? troublesHootInG counterselection, pcr identification and sequencing of mutations in P. aeruginosa cells • tIMInG 9 h (over 6 d) 37| Pick an isolated single colony from the surface of one of the VBMM agar plates prepared in Step 36A(xi) (or Step 36B(iii)) with an inoculation loop. Use the inoculation loop to streak the colony onto NSLB + 15% (wt/vol) sucrose agar. Incubate this plate for 36-48 h at 30 °C.
? troublesHootInG 38| Use a P20 micropipette to collect a tiny amount of a bacterial colony from the NSLB + 15% (wt/vol) sucrose agar plate and suspend it in 50 µl of ultrapure water. Typically, eight colonies from each NSLB + 15% (wt/vol) sucrose plate are screened for the desired mutation.  crItIcal step When in suspension, the bacteria should be only faintly turbid. The use of too much starting material can inhibit the downstream PCR.
39|
Use a multichannel pipette to transfer 3 µl of each colony in suspension onto three types of agar media: LB agar, Pseudomonas isolation agar (PIA) and LB agar containing the antibiotic used for merodiploid selection. Let these plates dry and then incubate them overnight at 37 °C.  crItIcal step Retain these plates at 4 °C. Note that spots on LB or PIA agar will grow into a colony that can be streaked out for isolation (in Step 49) once the clone with the desired mutation has been identified by PCR and/or Sanger sequencing (as described in Steps 40-48).
40|
Boil the remaining colonies in suspension using a thermocycler set at 100 °C for 5 min. After boiling, add 109 µl of ultrapure water to each well in order to dilute the starting concentration of gDNA.  crItIcal step If the template concentration is too high, DNA polymerase can be inhibited.
41|
Create a colony PCR master mix using GoTaq flexi DNA polymerase as follows: 
45|
Identify the unmarked mutants from the PCRs using option A if the goal is to produce a large (≥25 bp) deletion or insertion, or by sequencing using option B if the goal is to produce a SNP or short (<25 bp) deletion or insertion mutation.  crItIcal step Merodiploids frequently produce multiple bands in colony PCRs and will be positive for growth on LB agarcontaining antibiotic selection. Any contaminating E. coli from the conjugation will grow on LB agar, but it will not grow on PIA.
(a) Identifying mutants with large (≥25 bp) deletion or insertion mutations (i) Identify the PCRs corresponding to the desired mutants from the gel images taken in Step 44. Double-crossover mutants will have one of two potential PCR products: a band corresponding to a wild-type allele or another band corresponding to the mutant allele. In addition, these mutants will have grown on LB and PIA agar, and they will not have grown on LB agar containing antibiotic selection.
(ii) Purify the PCR products corresponding to two of the engineered mutants selected at the previous step. If the PCR produced a single band on the gel (corresponding to the target region of the genome), clean up the reaction using a PCR clean-up kit (e.g., QIAquick PCR purification kit), according to the manufacturer's instructions. Alternatively, if the PCR produced multiple bands on the gel, use a razor blade to cut out the DNA band of the expected size. Purify the DNA using a gel extraction kit (e.g., QIAEX II gel extraction kit) and elute the DNA in ultrapure water, according to the manufacturer's instructions. (iii) Determine the concentration and purity of the eluted DNA by measuring the A 260 and A 280 on a UV spectrophotometer. (b) Identifying mutants with snps or small (<25 bp) insertions and deletions (i) As it may not be possible to identify SNPs or small insertion or deletion mutations from the gel image (see Experimental design), Sanger sequencing may be used for this purpose. Purify the PCR products from
Step 44 for all of the colonies arrayed in
Step 39 that are sucrose-resistant and antibiotic-sensitive, as described in Step 45A(ii,iii).
? troublesHootInG 46| Send the purified PCR products from Step 45A(ii) and 45B(i) for Sanger sequencing. Use the primers 'Seq-F' and 'Seq-R' in each of two different sequencing reactions in order to sequence each of the PCR products.
47| Analyze the sequence of the PCR products using the BLASTN algorithm against the target P. aeruginosa genome (http://www.pseudomonas.com). If the goal was to produce a deletion mutation, the alignment will produce a match to two regions in the bacterial chromosome: one upstream and the other downstream of mutated region of DNA. For an insertion mutation, the BLASTN alignment will produce a match to one or two regions of the bacterial chromosome, depending on both the insertion and Sanger sequencing read length. For a SNP or small insertion or deletion mutation, an alignment for one region with a mismatch or gap will be reported by the algorithm.
? troublesHootInG 48| For every precisely engineered mutant, pick two colonies from Step 39 corresponding to the desired unmarked mutation. Streak each of these out on LB agar and incubate these plates at 37 °C overnight. Counter-selection escape; merodiploid has acquired the inactivating mutation in sacB; allelic exchange vector has the inactivating mutation in sacB; counter-selective medium was incorrectly prepared
49|
Repeat electroporation or conjugation with corrected merodiploid selection; repeat counter-selection; double-check the sequence of sacB in allelic exchange vector; double-check the composition of the counterselective medium
45B(i), 47
Multiple bands on the gel were produced by PCR Nonspecific DNA amplification Modify the PCR protocol to increase its stringency; if multiple PCR products cannot be separated effectively by electrophoresis, use a nested sequencing primer for the mutant allele; re-design 'Seq-F' and 'Seq-R' primers antIcIpateD results As a demonstration, we have used the present protocol to generate a set of 25 mutants with deletions in genes encoding structural and regulatory components of the type IV pilus (T4P). The P. aeruginosa T4P is well studied for its role in twitching motility, a form of bacterial translocation across moist surfaces. Twitching motility is easy to quantify by staining bacteria and measuring the motility zone at the plastic-agar interface in standard Petri plates 94, 95 . Many genes required for T4P biosynthesis and function are arranged in operons (Fig. 5a ), yet inactivating mutations in several of these genes do not abolish twitching motility. This includes, for example, fimT, pilY2, pilH and chpB 95, 96 (Fig. 5b) . Genes of the T4P range in size from 357 bp (pilZ) to 7,419 bp (chpA). Thus, systematic disruption of T4P genes illustrates the success of this protocol at making precise deletions (both large and small) at a variety of genome loci. In addition, this demonstration has provided benchmark data for anticipated outcomes that are discussed below, but note that ANTICIPATED RESULTS for primer design, PCR and cloning steps are presented in the supplementary tutorial and supplementary Figures 2 and 3 . Finally, all primers, strains and plasmids used in this demonstration and in the supplementary tutorial are summarized in supplementary tables 1-3, respectively.
Merodiploid selection (step 36)
By using this protocol, ~5.0 × 10 2 merodiploids were obtained per biparental mating per 1 kb of vector homology to the recipient chromosome (Step 36; Fig. 6a ). Similar numbers of merodiploids were produced using filter and puddle mating techniques (Step 36A versus Step 36B; Fig. 6a ). Novice users often point out that increasing incubation temperature from 30 to 37 °C during biparental mating increases the yield of merodiploids (Step 36A(ix) and Step 36B(ii); Fig. 6a ). However, merodiploids are routinely cultured at 30 °C to minimize clonal expansion. In principle, this decreases the number of bacterial generations and likelihood of random secondary site mutations in mutant strains. We have noted no difference in the number of merodiploids recovered from biparental mating of P. aeruginosa with either E. coli S17.1 or E. coli SM10 donor strains (supplementary Fig. 4) . Using standard procedures for serial dilution and viable cell counting 97 , we have estimated that merodiploids occur at a frequency of ~10 −7 in the bacterial population.
counter-selection and mutant detection (steps 37, 39, 45 and 48)
Single merodiploid colonies streaked out on NSLB + 15% (wt/vol) sucrose typically produce ~1.0 × 10 2 colonies (Step 37). Double crossovers occurred at a frequency of <10 −5 (Fig. 6b) . From a random sample of 52 antibiotic-sensitive colonies isolated on sucrose (representing 8 targeted loci: fimT, pilC, pilF, pilI, pilN, pilR, pilS and pilU), we were able to detect 24 (46%) with the desired double-crossover mutation by PCR (Step 45A). A total of 16 mutants were selected (two for each targeted locus), and all deletions were successfully confirmed by sequencing PCR products with nested sequencing primers (Step 48).
Mutations that cause counter-selection escape occur at a frequency of <10 −7 (Fig. 6b) . However, isolation of colonies that have escaped counter-selection is highly variable, which is typical of random mutation 98 . On the basis of our experience, ~5% of biparental matings produce merodiploid colonies that are antibiotic-and sucrose-resistant. However, we have observed that sucrose-resistant merodiploids may sometimes represent the vast majority of colonies isolated on sucrose from a single biparental mating (Step 39). It is tempting to speculate that this may be due to the timing at which a random mutation occurred (i.e., mutants emerging in early generations of bacterial cultures will expand to a large proportion of the population by late generations 98 ).
